Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JAMES TURRO

Allopathic & Osteopathic Physicians Internal Medicine

NPI
1497700561
CMS profile
804216
Location
MOUNT KISCO, NY

General Payments · PY2018–2024

$2,710.26

  • Reported across 163 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$755.51

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $755.51 35

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $202.12 13
Hologic Sales and Service, LLC $139.07 1
Acerta Pharma LLC $132.45 7
PFIZER INC. $90.83 5
Exact Sciences Corporation $55.19 2
Novo Nordisk AS $54.43 3
DEXCOM, INC. $47.75 2
Boehringer Ingelheim Pharmaceuticals, Inc. $33.67 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $562.91 41
PY2019 $402.28 21
PY2020 $241.51 17
PY2021 $157.55 11
PY2022 $171.08 12
PY2023 $419.42 26
PY2024 $755.51 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
AstraZeneca Pharmaceuticals LP $33.58 02/22/2024 Food and Beverage Undisputed 01/23/2026 1105223095 CMS
AstraZeneca Pharmaceuticals LP $17.06 05/21/2024 Food and Beverage Undisputed 01/23/2026 1105514319 CMS
AstraZeneca Pharmaceuticals LP $18.06 05/28/2024 Food and Beverage Undisputed 01/23/2026 1105571821 CMS
AstraZeneca Pharmaceuticals LP $15.25 06/04/2024 Food and Beverage Undisputed 01/23/2026 1105793202 CMS
AstraZeneca Pharmaceuticals LP $15.46 07/17/2024 Food and Beverage Undisputed 01/23/2026 1104643651 CMS
AstraZeneca Pharmaceuticals LP $17.06 08/14/2024 Food and Beverage Undisputed 01/23/2026 1105308285 CMS
AstraZeneca Pharmaceuticals LP $15.98 09/17/2024 Food and Beverage Undisputed 01/23/2026 1105609975 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $17.20 07/31/2024 Food and Beverage Undisputed 01/23/2026 1118033186 CMS
Boehringer Ingelheim Pharmaceuticals, Inc. $16.47 10/21/2024 Food and Beverage Undisputed 01/23/2026 1118033184 CMS
Dexcom, Inc. $23.76 01/30/2024 Food and Beverage Undisputed 01/23/2026 1153306209 CMS
Dexcom, Inc. $23.99 11/12/2024 Food and Beverage Undisputed 01/23/2026 1153306211 CMS
Exact Sciences Corporation $29.88 05/16/2024 Food and Beverage Undisputed 01/23/2026 1114936796 CMS
Exact Sciences Corporation $25.31 09/18/2024 Food and Beverage Undisputed 01/23/2026 1114936800 CMS
Hologic Sales and Service, LLC $139.07 04/16/2024 Food and Beverage Undisputed 01/23/2026 1084909530 CMS
Lilly USA, LLC $15.36 01/10/2024 Food and Beverage Undisputed 01/23/2026 1135045556 CMS
Lilly USA, LLC $17.20 02/13/2024 Food and Beverage Undisputed 01/23/2026 1135044490 CMS
Lilly USA, LLC $16.93 03/01/2024 Food and Beverage Undisputed 01/23/2026 1135039563 CMS
Lilly USA, LLC $15.60 04/10/2024 Food and Beverage Undisputed 01/23/2026 1135023262 CMS
Lilly USA, LLC $17.57 04/15/2024 Food and Beverage Undisputed 01/23/2026 1135045554 CMS
Lilly USA, LLC $3.14 04/25/2024 Food and Beverage Undisputed 01/23/2026 1135020878 CMS
Lilly USA, LLC $12.65 06/13/2024 Food and Beverage Undisputed 01/23/2026 1135020880 CMS
Lilly USA, LLC $16.75 06/18/2024 Food and Beverage Undisputed 01/23/2026 1135020876 CMS
Lilly USA, LLC $16.80 07/09/2024 Food and Beverage Undisputed 01/23/2026 1135020882 CMS
Lilly USA, LLC $17.05 08/21/2024 Food and Beverage Undisputed 01/23/2026 1135044488 CMS
Lilly USA, LLC $17.96 09/04/2024 Food and Beverage Undisputed 01/23/2026 1135039671 CMS
Lilly USA, LLC $18.53 10/23/2024 Food and Beverage Undisputed 01/23/2026 1135021348 CMS
Lilly USA, LLC $16.58 11/19/2024 Food and Beverage Undisputed 01/23/2026 1134993952 CMS
Novo Nordisk Inc $16.00 03/04/2024 Food and Beverage Undisputed 01/23/2026 1096826873 CMS
Novo Nordisk Inc $21.43 06/25/2024 Food and Beverage Undisputed 01/23/2026 1097489294 CMS
Novo Nordisk Inc $17.00 10/01/2024 Food and Beverage Undisputed 01/23/2026 1097783195 CMS
PFIZER INC. $16.39 02/20/2024 Food and Beverage Undisputed 01/23/2026 1132018478 CMS
PFIZER INC. $17.04 07/10/2024 Food and Beverage Undisputed 01/23/2026 1132011012 CMS
PFIZER INC. $17.06 10/08/2024 Food and Beverage Undisputed 01/23/2026 1132131519 CMS
PFIZER INC. $20.68 11/13/2024 Food and Beverage Undisputed 01/23/2026 1131139595 CMS
PFIZER INC. $19.66 12/03/2024 Food and Beverage Undisputed 01/23/2026 1131227465 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.